These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33401779)

  • 1. GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice.
    Biagetti B; Simó R
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
    Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Hormone's Links to Cancer.
    Boguszewski CL; Boguszewski MCDS
    Endocr Rev; 2019 Apr; 40(2):558-574. PubMed ID: 30500870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.
    van Esdonk MJ; van Zutphen EJM; Roelfsema F; Pereira AM; van der Graaf PH; Biermasz NR; Stevens J; Burggraaf J
    Pituitary; 2018 Jun; 21(3):310-322. PubMed ID: 29605877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and prevalence of hypertension in acromegaly.
    Bondanelli M; Ambrosio MR; degli Uberti EC
    Pituitary; 2001 Sep; 4(4):239-49. PubMed ID: 12501974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherent growth hormone resistance in the skeletal muscle of the fine flounder is modulated by nutritional status and is characterized by high contents of truncated GHR, impairment in the JAK2/STAT5 signaling pathway, and low IGF-I expression.
    Fuentes EN; Einarsdottir IE; Valdes JA; Alvarez M; Molina A; Björnsson BT
    Endocrinology; 2012 Jan; 153(1):283-94. PubMed ID: 22028448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans.
    Nishizawa H; Handayaningsih AE; Iguchi G; Cho Y; Takahashi M; Yamamoto M; Suda K; Kasahara K; Hakuno F; Yamanouchi K; Nishihara M; Seino S; Takahashi S; Takahashi Y
    Growth Horm IGF Res; 2012 Apr; 22(2):64-8. PubMed ID: 22370764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice.
    Iida K; Itoh E; Kim DS; del Rincon JP; Coschigano KT; Kopchick JJ; Thorner MO
    J Physiol; 2004 Oct; 560(Pt 2):341-9. PubMed ID: 15308683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like Growth Factors in a clinical setting: Review of IGF-I.
    Frysak Z; Schovanek J; Iacobone M; Karasek D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):347-51. PubMed ID: 26365932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
    Ho KY; Weissberger AJ
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine supplementation improves acquired growth hormone resistance in rats with protein-energy malnutrition.
    Gao X; Tian F; Wang X; Zhao J; Wan X; Zhang L; Wu C; Li N; Li J
    PLoS One; 2015; 10(4):e0125023. PubMed ID: 25909895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent regulation of proteasomes by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone.
    Chrysis D; Zhang J; Underwood LE
    Growth Horm IGF Res; 2002 Dec; 12(6):434-41. PubMed ID: 12423629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise and the growth hormone-insulin-like growth factor axis.
    Frystyk J
    Med Sci Sports Exerc; 2010 Jan; 42(1):58-66. PubMed ID: 20010129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid vascularity is increased in patients with active acromegaly.
    Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
    Rubinek T; Modan-Moses D
    Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.